Core Viewpoint - The company Xuan Zhu Bio-B (02575.HK) has announced a global offering of 67,333,500 H-shares at a price of HKD 11.60 per share, raising a net amount of HKD 701 million [1] Summary by Categories Offering Details - The global offering consists of 67,333,500 H-shares priced at HKD 11.60 each [1] - The net proceeds from the offering amount to HKD 701 million [1] Subscription Demand - The number of shares available for public offering in Hong Kong accounts for 10.00% of the total offering, with a subscription rate of 4,908.33 times [1] - The international offering represents 90.00% of the total shares, with a subscription rate of 10.15 times [1] Trading Information - If the global offering becomes unconditional by October 15, 2025, the H-shares are expected to start trading on the Hong Kong Stock Exchange at 9:00 AM (Hong Kong time) on the same day [1] - H-shares will be traded in lots of 500 shares, with the stock code 2575 [1]

Core Viewpoint - Xuan Zhu Bio-B (02575) has successfully completed its global offering, raising approximately HKD 701 million through the issuance of H-shares at a price of HKD 11.6 per share [1] Summary by Category Offering Details - The company issued a total of 67.33 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - Each board lot consists of 500 shares, and trading is expected to commence on October 15, 2025, at 9:00 AM Hong Kong time [1] Subscription Demand - The Hong Kong public offering was oversubscribed by 4,908.33 times, indicating strong local investor interest [1] - The international offering saw a subscription rate of 10.15 times, reflecting robust demand from global investors [1]

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 除本公告另有界定外，本公告所用詞彙與軒竹生物科技股份有限公司（「本公司」）日期為2025年 10月6日的招股章程（「招股章程」）所界定者具有相同涵義。 本公告僅供參考，並不構成收購、購買或認購任何證券的邀請或要約。本公告並非招股章程。 潛在投資者在決定是否投資於發售股份前，應細閱招股章程內有關下文所述全球發售的詳細資 料。有關發售股份的任何投資決定應僅依賴招股章程所提供的資料而作出。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發 佈、刊發或派發。本公告並不構成亦不屬於在美國境內或於任何其他司法權區購買或認購證券 的任何要約或招攬的一部分。本公告所述證券並無亦不會根據1933年美國證券法（經不時修訂） （「美國證券法」）或美國任何州或其他司法權區的證券法登記。證券不得在美國境內提呈發售、 出售、質押或以其他方式轉讓 ...

Core Viewpoint - Xuan Zhu Bio-B (02575) is set to list in Hong Kong on October 15, with significant pre-listing trading activity indicating strong investor interest, as evidenced by a 171.21% increase in its dark market price compared to the offering price [1] Group 1 - Xuan Zhu Bio-B's dark market trading price reached HKD 31.46, up from the offering price of HKD 11.60 [1] - The increase in price translates to a profit of HKD 9,930 per lot of 500 shares, excluding transaction fees [1]

26.20万 31.460 250( 150( 31.440 200( 31.420 31.400 MACD MACD(12,26,9):0.090 DIF:0.334 DEA:0.289 31.380 31.360 31.340 31.320 16:15 18:30 分时 1分 5分 日K 立即买入 立即卖出 • 行情来源: 利弗莫尔证券 • | V | | | 31.880 31.860 | | | --- | --- | --- | --- | --- | | | | | 31.840 31.820 31.800 | | | 11.600 | | | 31.780 | 200( | | | | | 31.760 | | | | | | 31.740 | | | | 일본의 일본 | | 31.720 | | | | | | 31.700 | 3000 | | | | | 31.500 | 200( | | -9.267 ● 价位 ● 均价 | | -179.89% | 31.480 | | | 分时量 量:0 | = | | | | 轩竹生物-B(02575)将于10月15日(周三)在香港挂牌。截至收盘 ...

Core Viewpoint - XuanZhu Bio-B's Hong Kong stock market dark trading surged over 158%, reaching HKD 30.00 [2] Company Summary - XuanZhu Bio-B experienced a significant increase in its stock price during dark trading, indicating strong investor interest and potential market confidence [2]

Core Viewpoint - Xuan Zhu Bio-B (02575) is set to list on the Hong Kong Stock Exchange on October 15, with pre-listing trading indicating a significant price increase from the initial offering price [1] Group 1: Company Overview - Xuan Zhu Bio-B's initial offering price is set at 11.60 HKD, with dark pool trading showing a current price of 30.96 HKD, representing a 166.9% increase [1] - The trading volume in the dark pool reached 494,500 shares, with a total market capitalization of 4.975 billion HKD [2] Group 2: Market Performance - The highest trading price recorded was 35.14 HKD, while the lowest was 23.02 HKD, indicating volatility in the early trading phase [2] - The average trading price during the session was 31.52 HKD, with a turnover rate of 0.31% [2]

Core Viewpoint - Xuan Zhu Bio-B (02575) is set to list on the Hong Kong Stock Exchange on October 15, with a significant increase in its dark trading price compared to its IPO price [1]. Group 1: Company Information - Xuan Zhu Bio-B's dark trading price is currently at 30.96 HKD, which represents a 166.9% increase from the IPO price of 11.60 HKD [1]. - Each trading unit consists of 500 shares, resulting in a potential profit of 9,680 HKD per unit, excluding transaction fees [1]. Group 2: Market Performance - The opening price was recorded at 23.02 HKD, with a trading volume of 494,500 shares and a highest price of 35.14 HKD [2]. - The stock has experienced a turnover rate of 0.31%, with a total market capitalization of 4.975 billion HKD [2]. - The average trading price during the session was 31.52 HKD, with a minimum price of 23.02 HKD [2].

董事名單與其角色及職能 軒竹生物科技股份有限公司董事會（「董事會」）成員載列如下： 執行董事 徐艷君女士 （董事長） 李嘉逵博士 （總經理） 史澂空博士 Xuanzhu Biopharmaceutical Co., Ltd. 軒竹生物科技股份有限公司 （一家於中華人民共和國註冊成立的股份有限公司） （股份代號：2575） 李惠英女士 尉麗峰先生 陳燕玲女士 獨立非執行董事 劉碩先生 王宇女士 范智超先生 董事會下設三個委員會。下表載列各董事會成員在該等委員會中所擔任的職位。 | | 委員會 | | 薪酬與 | | | --- | --- | --- | --- | --- | | 董事 | | 審計委員會 | 考核委員會 | 提名委員會 | | 徐艷君女士 | | | 成員 | 成員 | | 李嘉逵博士 | | | | | | 史澂空博士 | | | | | | 李惠英女士 | | | | | | 尉麗峰先生 | | | | | | 陳燕玲女士 | | 成員 | | | | 劉碩先生 | | | 成員 | 主席 | | 王宇女士 | | 成員 | 主席 | 成員 | | 范智超先生 | | 主席 | | | ...

軒竹生物科技股份有限公司 董事會提名委員會職責和議事規則 第一章 總則 第一條 為規範軒竹生物科技股份有限公司（以下簡稱「公司」）董事及高級 管理人員的產生，優化董事會和高級管理人員的組成，完善公司治理結構，根據 《中華人民共和國公司法》等有關法律、行政法規、規範性文件（合稱「國家法律 法規」）《香港聯合交易所有限公司證券上市規則》（以下簡稱「《香港上市規則》」） 及《軒竹生物科技股份有限公司章程》（以下簡稱「《公司章程》」），設立公司董事會 （以下簡稱「董事會」）下轄提名委員會（以下簡稱「委員會」），並制定本《軒竹生物 科技股份有限公司董事會提名委員會職責和議事規則》（以下簡稱「本細則」）。 第二條 委員會是董事會下設的專門工作機構，主要負責制定公司董事和高 級管理人員的人選、選拔標準和程序，進行考核並提出建議。 第三條 本細則所稱董事是指公司所有的董事，高級管理人員是指董事會聘 任的總經理、副總經理、財務總監、董事會秘書及《公司章程》規定的其他高級管 理人員。 第四條 委員會對董事會負責，並向董事會報告工作。 第五條 本細則適用於委員會及本細則中涉及的有關人員和部門。 第二章 委員會組成 第六條 委員會由 ...